Asabys, BPI France, Ysios in €30m series-A for Ona Therapeutics

Asabys, BPI France, Ysios in €30m series-A for Ona Therapeutics

Asabys Partners, alongside Alta Life Sciences, BPI France, Fund+ and Ysios Capital Partners, have invested in a €30m series-A round for drug development company Ona Therapeutics.

Read Previous

Zamo invests in SASC

Read Next

IQ appoints Hirtzel as general partner

Most Popular